This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

2024 ASCO® Annual Meeting Insights Hub
M

ASCO® 2024 Insights: "GABARNANCE Trial - Gemcitabine + nab-Paclitaxel vs. CRT With S-1 as Neoadjuvant Treatment for Borderline Resectable Pancreatic Cancer"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Masafumi Ikeda
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Masafumi Ikeda
29 views
June 18, 2024
0 Comments
Login to view comments. Click here to Login

2024 ASCO® Annual Meeting Insights Hub: GI Videos

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Botensilimab + Balstilimab in Microsatell…

Feat. A. Bullock
12:27
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Biomarker-Directed Treatment for Pancreat…

Feat. J. Knox
12:29
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Fruquintinib in Refractory mCRC"

Feat. C. Eng
View All

Related Content

AUTOPLAY
57:44
Vogl, NY

Vogl,NY on How to Ask Good Questions at Medical Meetings

Feat. S. Vogl
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
21:33
Integrity CE

How Recent Data Impacts Pancreatic Cancer Management

Feat. M. Pishvaian
27:04
Fengting Yan

Cancer Screening Molecular Tools

12:50
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "The GIANT Trial (EA2186) - Gem & nab-…

Feat. E. Dotan
09:01
Integrity CE

Debates in Neoadjuvant Therapy in Resectable Pancreatic Cancer: Why …

Feat. L. Zheng
29:25
Northwestern Medicine Oncology and Hematology

Hyperprogression in Cancer Treated With Immunotherapy

Feat. Y. Chae
10:22
Houston Methodist Hospital

mRNA Vaccine in Treatment of Pancreatic Cancer

Feat. J. Gonzalez
27:37
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

Feat. N. Uboha, A. Turk, K. Spencer, M. Cecchini
08:34
Yale Cancer Center

NORPACT-1 Trial Updates: Neoadjuvant FOLFIRINOX vs. Upfront Surgery …

Feat. J. Lacy
23:58
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Key Studies

Feat. R. Kim, R. Mehta
31:40
Horizon CME

Updates in Perioperative Therapy of Pancreatic Cancer

Feat. P. Philip
20:07
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "GI Expert Panel Discussion on Key Trials I…

Feat. Y. Janjigian, S. Cytryn, S. Maron
17:05
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Advancing GI Cancer Treatment - The Clinic…

Feat. S. Cohen
07:42
Integrity CE

Debates in Neoadjuvant Therapy in Resectable Pancreatic Cancer: Why …

Feat. W. Burns
17:02
Harshabad Singh

Targeting KRAS in Pancreatic Cancer

06:03
Total Health

2024 Updates on Targeted Approaches for GI Cancers and New Data in N…

Feat. A. Grothey
19:41
Balazs Halmos

How I Manage Immune Adverse Events in Solid Tumors

03:50
UCLA Health

Perspectives on the Recent FDA Approval of NALIRIFOX in Frontline Me…

Feat. Z. Wainberg
04:25
ecancer

ASCO® 2024 Insights: "Summary of the PASS-01 Trial - 1L FOLFIRI…

Feat. J. Knox